SUSCEPTIBILITY OF LYMPHOBLASTOID CELLS TO INFECTION WITH HUMAN CYTOMEGALO-VIRUS

[1] POST-TRANSFUSION CYTOMEGALOVIREMIA AND PERSISTENCE OF CYTOMEGALOVIRUS IN BLOOD [J]. INFECTION AND IMMUNITY, 1971, 3 (01) : 159 - +

[2] EPSTEIN MA, 1966, J NATL CANCER I, V37, P547

[3] EPSTEIN MA, 1964, LANCET, V1, P252

[4] EPIDEMIOLOGY OF CYTOMEGALOVIRUS-INFECTION AFTER TRANSPLANTATION AND IMMUNOSUPPRESSION [J]. JOURNAL OF INFECTIOUS DISEASES, 1975, 132 (04) : 421 - 433

[5] FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO

[6] 2-J

[7] GEHRZ RC, 1977, LANCET, V2, P844

[8] HARDEN DG, 1967, BLOOD, V30, P120

[9] HINUMA Y, 1967, P SOC EXP BIOL MED, V124, P107

[10] HUANG ES, 1974, ONCOGENESIS HERPESVI, V2, P475

[1] POST-TRANSFUSION CYTOMEGALOVIREMIA AND PERSISTENCE OF CYTOMEGALOVIRUS IN BLOOD [J]. INFECTION AND IMMUNITY, 1971, 3 (01) : 159 - +

[2] EPSTEIN MA, 1966, J NATL CANCER I, V37, P547

[3] EPSTEIN MA, 1964, LANCET, V1, P252

[4] EPIDEMIOLOGY OF CYTOMEGALOVIRUS-INFECTION AFTER TRANSPLANTATION AND IMMUNOSUPPRESSION [J]. JOURNAL OF INFECTIOUS DISEASES, 1975, 132 (04) : 421 - 433

[5] FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO

[6] 2-J

[7] GEHRZ RC, 1977, LANCET, V2, P844

[8] HARDEN DG, 1967, BLOOD, V30, P120

[9] HINUMA Y, 1967, P SOC EXP BIOL MED, V124, P107

[10] HUANG ES, 1974, ONCOGENESIS HERPESVI, V2, P475